According to the Graphical Research new growth forecast report titled “Europe Apheresis Equipment Market Forecast By Product, Application, Procedure, Technology, Industry Analysis Report, Regional Outlook”, Estimated To Exceed USD 1.2 Billion By 2026. Increasing geriatric population susceptible to chronic diseases will serve to be a high impact rendering factor for apheresis equipment market. According to the European Commission, around 19.2% of the total population in the EU-28 countries are over 65 years of age. Higher proportion of elderly population are suffering from various chronic illnesses such as cancer, cardiovascular diseases, renal disorders, anemia, lung disorders, hepatitis and arthritis. Owing to the vulnerability to these diseases among geriatric pool, the requirement of transfusion of blood and blood components will lead to robust market growth in the region.
Presence of favorable regulatory environment will boost the market growth in the foreseeable future. Various initiatives related to the quality and safety for collecting, processing, storing and distributing blood and blood components are taken by various regulatory governing bodies. These directives are undertaken in response to the rising need of blood and plasma for patients requiring plasma transfusions and derived products for their survival. The European Commission has developed directives 2001/83/EC and 2002/98/EC to encourage blood collection through voluntary unpaid donations. Furthermore, Article 110 of Directive 2001/83/EC also encourages the manufacturers to produce blood derived or human plasma derived medicinal products used to treat different blood related disorders. Such factors will prove beneficial to augment the demand for apheresis equipment in future.
However, unavailability of donor and specific blood group hinder the growth of market in Europe.
Based on product, the industry is segmented as disposable apheresis kits and apheresis machines. Disposable apheresis kit segment is estimated to witness around 11.0% CAGR during the forecasting timeframe. Availability of premium quality of kits for effective pain management will foster segment growth during the analysis timeframe. Furthermore, low prices and large volume procurement of disposable apheresis kits will aid in market growth.
On the basis of application, the market is classified as renal disease, neurology, hematology and others. Neurology segment held more than 50% revenue share in 2019. This is attributed to increasing occurrence of neurological disorders such as multiple sclerosis and myasthenia gravis. According to the European Academy of Neurology (EAN), prevalence of neurological diseases in EU-28 was recorded to be around 307 million. Healing plasma exchange is one of the vital treatments for these diseases. Additionally, increasing investment in R&D will spur the market growth in foreseeable future.
On the basis of procedure, the industry is segmented as photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis and others. LDL apheresis segment accounted for over USD 34.0 million in 2019. LDL apheresis is an extracorporeal removal of low-density lipoprotein cholesterol and sending back the remaining blood into the body. The technique is recommended if cholesterol levels are high despite the drug treatment and cholesterol management. The procedure is highly preferred as high level of cholesterol significantly increases the risk of heart disease among patients. However, eligibility criteria for LDL apheresis and the number of people receiving treatment vary from country to country in Europe, thereby impacting the market growth.
Based on technology, the market comprises of membrane filtration and centrifugation. Membrane filtration segment is projected to show around 11.0% CAGR lucrative during the forecast period. Membrane filtration is involved in separation of plasma. In this technique, blood is pumped through the membrane made up of thin layer of semi-permeable material and separates blood component from plasma. This is done by allowing the plasma to pass through, while retaining the blood components. Membrane filtration technique is extensively used in the European region as it is a cheaper and faster technique for plasma separation and will thus boost its demand in the upcoming years.
France apheresis equipment market is estimated to witness around 12.5% CAGR during the forthcoming years. This is attributed to increasing healthcare expenditure, and rising incidence of blood related disorders. For instance, sickle cell disease (SCD) is a major disease in France. The SCD population in France is about 8,000 patients. Thus, large patient pool and high requirement of transfusion in such patients will contribute to apheresis equipment business growth in France.
Major market players involved in the market are Fresenius SE & Co. KGaA, Cerus Corporation, B. Braun Melsungen AG, Haemonetics Corporation among others. These market players are undertaking strategies such as agreement, collaborations and acquisition to gain competitive over others.
Europe apheresis equipment market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:
Europe Apheresis Equipment Market Share, By Product, 2015-2026 (USD Million)
- Disposable Apheresis Kits
- Apheresis Machines
Europe Apheresis Equipment Market Size, By Application, 2015-2026 (USD Million)
- Renal Disease
Europe Apheresis Equipment Market Value, By Procedure, 2015-2026 (USD Million)
- LDL Apheresis
Europe Apheresis Equipment Market Forecast, By Technology, 2015-2026 (USD Million)
- Membrane Filtration
The above information is provided for the following region and countries:
- The Netherlands